Markets:

Overview

News

Currencies

International

Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

15.82 +0.04 (+0.25%)

Official Closing Price Updated: 7:00 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Bausch + Lomb Corporation Common Shares

< Previous 1 2 3 4 5 Next >

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

April 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program

April 16, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe

April 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting

April 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29

March 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

March 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches R&D “Teach-in” Webinar Series

March 09, 2026

From Bausch + Lomb Corporation

Via Business Wire

Ophthalmology and Therapy Publishes Findings Showing Lifestyle-Driven Rise in Ocular Redness and Differentiated Role of LUMIFY®

February 24, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance

February 18, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18

January 20, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

January 05, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

January 02, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 23, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Two Board of Directors Appointments

December 17, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Refinancing of Outstanding Term B Loans

December 12, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in Citi Global Healthcare Conference

November 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day

November 13, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program

November 10, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Hold Investor Day on Nov. 13

November 03, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Third-Quarter 2025 Results

October 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

September 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial

September 11, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers

September 09, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

September 08, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Board Changes

August 18, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in Upcoming Investor Conferences

August 14, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second-Quarter 2025 Results

July 30, 2025

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops

July 29, 2025

From Bausch + Lomb Corporation

Via Business Wire

Artificial Intelligence Influence in Ophthalmology Industry Projected to Create a Billion Dollar Revenue Opportunity

July 22, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(NASDAQ:TEM) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

July 01, 2025

From Bausch + Lomb Corporation

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.